Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Cebranopadol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tris shows its opioid alternative is less likely to be abused
    Tris shows its opioid alternative is less likely to be abused

    28 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tris-builds-clinical-case-opioid-alternative-showing-pain-drug-less-likely-be-abused

    FIERCE BIOTECH
    28 Jan 2025
    Share Share
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024
    Tris Pharma's Cebranopadol Shows Prolonged Pain Relief at PAINWeek 2024

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903523518/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol
    Tris Pharma Starts Phase 3 Trials For Novel Pain Treatment Cebranopadol

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821421996/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment
    Tris Pharma Presents Data On Cebranopadol For Pain Treatment

    06 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805194778/en

    BUSINESSWIRE
    06 Aug 2024
    Share Share
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress
    Tris Pharma To Present Pain Therapy Data At IASP 2024 Congress

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730108785/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol
    Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Cebranopadol

    05 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230905720896/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share